Guideline Intelligence
Every guideline, every country, side by side.
1,840 active guidelines extracted into structured recommendations with GRADE evidence, update history and machine-readable algorithms.
HypertensionDiabetesSepsisTuberculosisMaternal healthHIV / PrEPAMR stewardship
WHO · 2024
Antenatal care for a positive pregnancy experience
49 recommendationsGRADE: Strong / Moderate
NICE · 2025
Type 2 diabetes in adults: management (NG28)
78 recommendationsGRADE: Strong
ESC · 2024
Acute coronary syndromes 2024
142 recommendationsGRADE: Class I / IIa
CDC · 2025
Sexually transmitted infections treatment, 2025 update
96 recommendationsGRADE: Strong / Moderate
ADA · 2026
Standards of Care in Diabetes — 2026
184 recommendationsGRADE: A / B / C
Rwanda MoH · 2025
Integrated Management of Childhood Illness — national protocol
64 recommendationsGRADE: National
Cross-Guideline Comparator
WHO · NICE · ESC · ADA
| Clinical question | WHO | NICE | ESC | ADA |
|---|---|---|---|---|
| First-line antihypertensive in CKD | ACEi / ARB | ACEi / ARB | ACEi / ARB | ACEi / ARB |
| HbA1c target (older adults) | <8.0% | <7.5% | <8.0% | <8.0% |
| Statin in primary prevention (10y risk) | ≥10% | ≥10% (QRISK3) | ≥7.5% (SCORE2) | ≥7.5% |
| Empirical antibiotic, CAP outpatient | Amoxicillin | Amoxicillin | — | — |